Your session is about to expire
← Back to Search
Exparel Administration for Hip Fracture (HEAT Trial)
HEAT Trial Summary
This trial will study whether Liposomal Bupivacaine (Exparel) is effective in reducing pain for hip fracture patients undergoing hip hemiarthroplasty for femoral neck fractures.
- Hip Hemiarthroplasty
- Femoral Neck Fracture
HEAT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HEAT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You had a surgery that is not hip hemiarthroplasty.You have a broken hip bone that extends beyond its normal boundary.
- Group 1: Saline
- Group 2: Bupivacaine liposome
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there other findings connected to the utilization of Bupivacaine liposome?
"As of now, 18 Phase 3 trials for Bupivacaine liposome are active and being conducted at a total of 109 locations. Most studies are located in Philadelphia, Pennsylvania; however 144 sites around the world have opened their doors to this study."
What conditions is Bupivacaine liposome typically prescribed to alleviate?
"Bupivacaine liposome is the go-to treatment for pemphigus, but it has also been known to effectively tackle other conditions like acute nonspecific tenosynovitis, general anesthesia, and lupus erythematous."
Is this venture currently recruiting participants?
"This research study is currently open for patient enrollment, as indicated on clinicaltrials.gov. Its first listing was made on March 1st 2018 and it was last updated on August 9th 2022."
Has the United States Food and Drug Administration accepted Bupivacaine liposome as a viable medical treatment?
"We at Power have concluded that Bupivacaine liposome is a safe treatment, awarding it with a 3 out of 3 rating. This judgement was made as the medication has already received FDA approval and thus entered its fourth stage of clinical trial."
How many individuals are accepted into this research endeavor?
"Affirmative. Clinicaltrials.gov exhibits that this experiment is open to recruitment and was first published on March 1st, 2018. The most recent update was August 9th, 2022 and the study requires 50 volunteers across a single medical site."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger